Keywords: medco, study, finds, ppis, reduce, effectiveness, plavix
Medco study finds PPIs reduce effectiveness of Plavix in CV treatment
Article | 08 May 2009
Four of the most commonly-prescribed heartburn medications reduce the effectiveness of French and US drug majors Sanofi-Aventis and Bristol-Myers Squibb's ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
